FDA Approved: CELECOXIB — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)

View source ↗

Summary

The FDA approved a supplemental application for Celecoxib submitted by NIVAGEN Pharmaceuticals, Inc., for a generic Celecoxib product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dental Pain
• Dysmenorrhea
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Postoperative Pain
• Rheumatoid Arthritis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

SUPPL AP for CELECOXIB (CELECOXIB)